伏硫西汀联合正念减压治疗急性创伤后应激性障碍患者的临床效果

王明君, 郑景珍, 李兴, 金亚军, 杨芳

王明君, 郑景珍, 李兴, 金亚军, 杨芳. 伏硫西汀联合正念减压治疗急性创伤后应激性障碍患者的临床效果[J]. 实用临床医药杂志, 2023, 27(8): 71-75. DOI: 10.7619/jcmp.20223045
引用本文: 王明君, 郑景珍, 李兴, 金亚军, 杨芳. 伏硫西汀联合正念减压治疗急性创伤后应激性障碍患者的临床效果[J]. 实用临床医药杂志, 2023, 27(8): 71-75. DOI: 10.7619/jcmp.20223045
WANG Mingjun, ZHENG Jingzhen, LI Xing, JIN Yajun, YANG Fang. Clinical effect of vortioxetine combined with mindfulness decompression in treating acute post-traumatic stress disorder patients[J]. Journal of Clinical Medicine in Practice, 2023, 27(8): 71-75. DOI: 10.7619/jcmp.20223045
Citation: WANG Mingjun, ZHENG Jingzhen, LI Xing, JIN Yajun, YANG Fang. Clinical effect of vortioxetine combined with mindfulness decompression in treating acute post-traumatic stress disorder patients[J]. Journal of Clinical Medicine in Practice, 2023, 27(8): 71-75. DOI: 10.7619/jcmp.20223045

伏硫西汀联合正念减压治疗急性创伤后应激性障碍患者的临床效果

详细信息
    通讯作者:

    杨芳, E-mail: shuixianyf@126.com

  • 中图分类号: R749;R971

Clinical effect of vortioxetine combined with mindfulness decompression in treating acute post-traumatic stress disorder patients

  • 摘要:
    目的 

    观察伏硫西汀联合正念减压治疗急性创伤后应激性障碍患者的临床效果。

    方法 

    选取118例急性创伤后应激性障碍患者,随机分为观察组和对照组,每组59例。观察组以伏硫西汀联合正念减压治疗,对照组以正念减压疗法联合安慰剂治疗。

    结果 

    观察组总有效率为91.53%(54/59), 高于对照组的76.27%(45/59), 差异有统计学意义(P < 0.05)。治疗后,观察组患者的心理弹性量表(CD-RISC)评分包括坚韧性、力量、乐观性及总分均高于对照组,观察组患者钙调蛋白(CaM)、促肾上腺皮质激素(ACTH)、人抗酒石酸酸性磷酸酶(TRAP)水平低于对照组,观察组8-羟化脱氧鸟苷(8-OHdG)、髓过氧化物酶(MPO)水平低于对照组,谷胱甘肽过氧化物酶(GSH-Px)水平高于对照组,差异均有统计学意义(P < 0.05)。观察组、对照组不良反应发生率为13.56%(8/59)、8.47%(5/59), 差异无统计学意义(P>0.05)。

    结论 

    伏硫西汀联合正念减压治疗急性创伤后应激性障碍疗效良好,可改善患者心理弹性,降低炎症反应水平和氧化应激状态。

    Abstract:
    Objective 

    To observe the clinical effect of vortioxetine combined with mindfulness decompression in the treatment of patients with acute post-traumatic stress disorder.

    Methods 

    A total of 118 patients with acute post-traumatic stress disorder were selected and randomly divided into observation group and control group, with 59 cases in each group. The observation group was treated with vortioxetine and mindfulness decompression, while the control group was treated with mindfulness decompression and placebo.

    Results 

    The total effective rate of the observation group was 91.53%(54/59), which was significantly higher than 76.27% (45/59) of the control group (P < 0.05). After treatment, the scores of tenacity, strength, optimism and total score of the Connor-Davidson Resilience Scale (CD-RISC) in the observation group were higher than those in the control group; the levels of calmodulin (CaM), adrenocorticotropic hormone (ACTH) and human tartrate resistant acid phosphatase (TRAP) in the observation group were lower than those in the control group; the levels of 8-hydroxydeoxyguanosine (8-OHdG) and myeloperoxidase (MPO) in the observation group were significantly lower than those in the control group, while the level of glutathione peroxidase (GSH-Px) was significantly higher than that in the control group (P < 0.05). The incidence rate of adverse reactions was 13.56% (8/59) in the observation group and 8.47%(5/59) in the control group, and there was no significant difference between two groups (P>0.05).

    Conclusion 

    Vortioxetine combined with mindfulness decompression is effective in the treatment of patients with acute post-traumatic stress disorder, which can improve psychological resilience, and reduce the level of inflammatory reaction and oxidative stress of patients.

  • 表  1   2组临床疗效比较[n(%)]

    组别 n 显效 有效 无效 总有效
    对照组 59 28(47.46) 17(28.81) 14(23.73) 45(76.27)
    观察组 59 34(57.63) 20(33.90) 5(8.47) 54(91.53)*
    与对照组比较, *P < 0.05。
    下载: 导出CSV

    表  2   2组心理弹性评分比较$\left( {\bar x \pm s} \right) $     

    组别 时点 坚韧性 力量 乐观性 总分
    对照组(n=59) 治疗前 22.09±4.98 11.78±3.11 6.28±1.89 40.15±6.09
    治疗后 38.17±5.36* 24.46±4.78* 9.03±2.56* 71.66±8.06*
    观察组(n=59) 治疗前 21.12±4.48 11.23±3.02 6.17±1.79 38.52±5.97
    治疗后 44.38±5.99*# 28.20±3.82*# 11.22±2.89*# 83.80±9.83*#
    与治疗前比较, *P < 0.05; 与对照组比较, #P < 0.05。
    下载: 导出CSV

    表  3   2组炎症因子指标水平比较$\left( {\bar x \pm s} \right) $     ng/L

    组别 时点 CaM ACTH TRAP
    对照组(n=59) 治疗前 75.31±8.37 120.75±14.21 31.28±5.11
    治疗后 46.81±5.96* 80.39±11.54* 18.95±3.97*
    观察组(n=59) 治疗前 76.37±8.92 121.87±14.37 32.18±5.26
    治疗后 39.38±5.83*# 68.27±8.31*# 14.32±3.39*#
    CaM: 钙调蛋白; ACTH: 促肾上腺皮质激素; TRAP: 人抗酒石酸酸性磷酸酶。与治疗前比较, *P < 0.05; 与对照组比较, #P < 0.05。
    下载: 导出CSV

    表  4   2组氧化应激指标比较$\left( {\bar x \pm s} \right) $     U/L

    组别 时点 8-OHdG MPO GSH-Px
    对照组(n=59) 治疗前 64.02±7.86 120.89±13.11 56.92±6.33
    治疗后 44.88±6.03* 84.23±8.92* 84.02±9.16*
    观察组(n=59) 治疗前 65.22±8.74 122.33±14.32 57.38±6.29
    治疗后 37.26±5.97*# 78.80±8.72*# 93.37±10.29*#
    8-OHdG: 8-羟化脱氧鸟苷; MPO: 髓过氧化物酶; GSH-Px: 谷胱甘肽过氧化物酶。与治疗前比较, *P < 0.05; 与对照组比较, #P < 0.05。
    下载: 导出CSV

    表  5   2组不良反应发生率比较[n(%)]

    组别 n 头晕恶心 呕吐腹泻 面部潮红 盗汗 合计
    对照组 59 2(3.39) 1(1.69) 1(1.69) 1(1.69) 5(8.47)
    观察组 59 2(3.39) 2(3.39) 2(3.39) 2(3.39) 8(13.56)*
    与对照组比较, *P < 0.05。
    下载: 导出CSV
  • [1] 黄燕琳, 刘春琳, 刘钰瑞, 等. 创伤后应激障碍症状严重程度与事件相关电位关联性研究进展[J]. 临床军医杂志, 2021, 49(11): 1282-1285, 1289. doi: 10.16680/j.1671-3826.2021.11.34
    [2]

    ALMUWAQQAT Z, AN Y, GARCIA M, et al. Abstract 014: Posttraumatic Stress Disorder, Mental Stress-induced Myocardial Ischemia And Cardiovascular Outcomes In Patients With CAD[J]. Circulation, 2021, 143(1): 281-284.

    [3]

    KIESEPPÄ V, JOKELA M, HOLM M, et al. Post-traumatic stress disorder among immigrants living in Finland: Comorbidity and mental health service use[J]. Psychiatry Res, 2021, 300: 113940. doi: 10.1016/j.psychres.2021.113940

    [4] 张祥祥, 沈新华, 何为民, 等. 阶段性康复训练结合正念减压疗法在精神科疾病患者康复中的应用意义[J]. 重庆医学, 2020, 49(24): 4136-4139. doi: 10.3969/j.issn.1671-8348.2020.24.022
    [5] 宋昌群, 张雨轶, 吴珍. 正念减压疗法对新冠疫情期间老年胃食管反流病患者心理状态和睡眠质量的影响分析[J]. 世界华人消化杂志, 2021, 29(1): 48-52.
    [6] 周小艳, 冉江峰, 范征莉, 等. 伏硫西汀与文拉法辛治疗伴认知功能损害抑郁症临床疗效对比[J]. 中国药业, 2020, 29(12): 79-81. doi: 10.3969/j.issn.1006-4931.2020.12.022
    [7] 戴云飞, 肖泽萍. 中国精神障碍分类与诊断标准第3版与国际疾病分类第10版的比较[J]. 临床精神医学杂志, 2013, 23(6): 426-427. https://www.cnki.com.cn/Article/CJFDTOTAL-LCJS201306035.htm
    [8] CSNP精神病性障碍研究联盟全体成员. 中国精神病临床高危综合征早期识别和干预—CSNP精神病性障碍研究联盟专家共识(2020版)[J]. 中国神经精神疾病杂志, 2020, 46(4): 5-11.
    [9] 杨静, 于文平, 胡志, 等. 心理弹性量表简版在机构养老老年人群体中的适用性[J]. 中国临床心理学杂志, 2020, 28(3): 499-502. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLCY202003015.htm
    [10] 姜珺, 李志武, 康瑞莹, 等. 改良式"重返社区技能训练" 对社区精神分裂症患者症状、认知及社会功能的干预效果研究[J]. 中国全科医学, 2018, 21(4): 475-479.
    [11]

    VASILYEVA E F, BRUSOV O S. Cellular and Molecular Mechanisms of Proinflammatory Monocytes Participation in the Pathogenesis of Mental Disorders. Part 2[J]. Medical Informational Agency Publishers, 2020, 29(4): 1771-1775.

    [12]

    YVCEL E M, KONDUK B T, SARACALOGLU A, et al. Investigation of dynamic thiol/disulfide homeostasis and nitrosative stress in patients with Wilson disease[J]. Turkish J Gastroenterol, 2021, 32(9): 765-773.

    [13] 林正华, 章琳, 王继尧. 正念认知疗法在住院精神障碍患者中的应用效果[J]. 中国医药导报, 2020, 17(5): 83-86.
    [14] 马旭霞, 岳莹莹, 袁勇贵. 伏硫西汀改善抑郁症患者认知功能障碍的Meta分析[J]. 中华精神科杂志, 2022, 55(1): 56-63.
    [15] 潘秀娟, 刘林晶. 伏硫西汀治疗首发抑郁症患者的临床效果观察[J]. 中国基层医药, 2020, 27(9): 1035-1039.
    [16] 矫健萍, 胡健波, 黄满丽. 伏硫西汀对抑郁症疗效、认知功能和BDNF影响的研究进展[J]. 中国现代医生, 2020, 58(9): 184-188.
    [17] 梁萍娟, 梁明媚, 于志军, 等. 伏硫西汀与文拉法辛治疗抑郁症的临床疗效观察[J]. 中国现代药物应用, 2021, 15(11): 27-30. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWYY202111008.htm
    [18]

    BOHUSH A, LESNIAK W, WEIS S, et al. Calmodulin and its binding proteins in parkinson′s disease[J]. Int J Mol Sci, 2021, 22(6): 3016.

    [19]

    HALLEEN J M, ALATALO S L, JANCKILA A J, et al. Serum tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption[J]. Clin Chem, 2001, 47(3): 597-600.

    [20]

    TONARI M, NISHIKAWA Y, MATSUO J, et al. A case of giant pituitary adenoma associated with a postoperative mental disorder that ultimately resulted in bilateral blindness[J]. Case Rep Ophthalmol, 2020, 11(1): 92-99.

    [21] 奥通沙·热合买提, 杨丽娟, 阿不都热合满·买买提, 等. 后循环缺血性头晕患者发生认知功能障碍与血管内皮功能、氧化应激和脑白质改变的相关性研究[J]. 中国医药导报, 2022, 19(5): 71-74.
  • 期刊类型引用(4)

    1. 王惠霞. 无创正压通气联合保金化痰利肺汤对慢阻肺急性加重期效果观察. 临床研究. 2024(01): 119-122 . 百度学术
    2. 岑坚兴,梁守敬,郑普光. 无创通气治疗老年COPD伴睡眠障碍的效果及对患者睡眠质量的影响. 世界睡眠医学杂志. 2022(05): 836-838 . 百度学术
    3. 杨雍,吕汝琦,刘丹. 早期无创正压通气对重症急性胰腺炎合并肺损伤的保护作用机制. 医学信息. 2019(03): 55-57 . 百度学术
    4. 李菡,周志刚. 无创正压通气联合呼吸兴奋剂治疗慢性阻塞性肺疾病合并肺性脑病的效果观察. 实用临床医药杂志. 2019(07): 68-71 . 本站查看

    其他类型引用(0)

表(5)
计量
  • 文章访问数:  129
  • HTML全文浏览量:  58
  • PDF下载量:  10
  • 被引次数: 4
出版历程
  • 收稿日期:  2022-09-29
  • 修回日期:  2023-01-09
  • 网络出版日期:  2023-05-10

目录

    /

    返回文章
    返回
    x 关闭 永久关闭